...
首页> 外文期刊>International Journal of Nanomedicine >A reusable localized surface plasmon resonance biosensor for quantitative detection of serum squamous cell carcinoma antigen in cervical cancer patients based on silver nanoparticles array
【24h】

A reusable localized surface plasmon resonance biosensor for quantitative detection of serum squamous cell carcinoma antigen in cervical cancer patients based on silver nanoparticles array

机译:基于银纳米粒子阵列的宫颈癌患者血清鳞状细胞癌抗原定量检测的可重复使用的局部表面等离子体共振生物传感器

获取原文

摘要

Abstract: Squamous cell carcinoma antigen (SCCa), as a tumor biomarker, plays an important role in adjuvant diagnosis, treatment evaluation, and prognosis prediction for cervical cancer patients. Localized surface plasmon resonance (LSPR) technique based on noble metal nanoparticles bypasses the disadvantages of traditional testing strategies, in terms of free-labeling, short assay time, good sensitivity, and selectivity. Herein, we develop a novel and reusable LSPR biosensor for the detection of SCCa. First, a triangle-shaped silver nanoparticle array was fabricated using the nanosphere lithography method. Next, we investigated and verified the feasibility of amino coupling method using 11-mercaptoundecanoic acid (MUA) to form a functionalized chip surface with monoclonal anti-SCCa antibodies on the silver nanoparticles for distinct detection of SCCa. Different concentrations of SCCa were successfully tested in both buffer and human serum by the ultrasensitive and specific LSPR system, with a linear quantitative detection range of 0.1–1,000 pM under optimal conditions. With appropriate regeneration solution, for example 50 mM glycine-HCl (pH 2.0), the LSPR biosensor featured effective fabrication reproducibility, which reduced both production cost and testing time. Our study represents the first application of the LSPR biosensor in cervical cancer, and demonstrates that the rapid, simple, and reusable nanochip can serve as a potential alternative for clinical serological diagnosis of SCCa in cervical cancer patients.
机译:摘要:鳞状细胞癌抗原(SCCA),作为肿瘤生物标志物,对宫颈癌患者的辅助诊断,治疗评估和预后预测起重要作用。基于贵金属纳米粒子的局部表面等离子体共振(LSPR)技术绕过传统测试策略的缺点,就自由标记,短测定时间,良好的敏感性和选择性。在此,我们开发一种用于检测SCCA的新型和可重复使用的LSP生物传感器。首先,使用纳米光光刻法制造三角形银纳米颗粒阵列。接下来,我们研究并验证了使用11-巯基烷酸(MUA)的氨基偶联方法的可行性,形成官能化芯片表面,用单克隆抗SCCA抗体在银纳米粒子上进行,用于不同的SCCA检测。通过超细胞传感和特定的LSPR系统在缓冲液和人血清中成功测试了不同浓度的SCCA,在最佳条件下具有线性定量检测范围为0.1-1,000μm。通过适当的再生溶液,例如50mM甘氨酸-HCl(pH 2.0),LSPR生物传感器具有有效的制造再现性,这减少了生产成本和测试时间。我们的研究代表了宫颈癌LSPR生物传感器的第一次应用,并证明了快速,简单,可重复使用的纳米磷脂可以作为宫颈癌患者SCCA临床血清学诊断的潜在替代方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号